Literature DB >> 17707892

Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer.

Robert E Mitchell1, Jay B Shah, Manisha Desai, Mahesh M Mansukhani, Carl A Olsson, Mitchell C Benson, James M McKiernan.   

Abstract

OBJECTIVES: To describe the changes in the Gleason grading system over time and evaluate how a shift in Gleason grading has affected the overall predictive accuracy of the system in predicting biochemical disease-free survival after radical prostatectomy.
METHODS: The Columbia University Urologic Oncology Database was reviewed, and 1515 patients who met the inclusion criteria were identified who had undergone radical prostatectomy from 1988 to 2004. The patients were divided into two time cohorts (1988 to 1997 and 1998 to 2004). To determine whether a shift in the Gleason sum distribution has occurred, a chi-square test was performed. Survival curves and log-rank tests were used to compare the biochemical disease-free survival between cohorts stratified by the Gleason sum. To estimate the predictive ability of the Gleason system over time, concordance indexes were calculated.
RESULTS: A shift toward greater Gleason sums over time was confirmed using the chi-square test (P <0.001). A significant difference was observed in biochemical disease-free survival between the two time cohorts for those with Gleason sum 6 cancer (P <0.01). The concordance indexes corresponding to Gleason sum alone for each time cohort were 0.71 and 0.87, demonstrating that the Gleason sum's predictive ability improved significantly over time. After adjusting for other variables, the Gleason sum continued to demonstrate a significantly improved predictive ability in the more recent time cohort.
CONCLUSIONS: We found a trend toward the assignment of increasing Gleason sums over time in our data set. This shift in Gleason sum distribution between the two time cohorts has resulted in a significant improvement in the predictive ability of the Gleason system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707892     DOI: 10.1016/j.urology.2007.06.1084

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.

Authors:  Andrew J Vickers; Caroline J Savage; Fernando J Bianco; Eric A Klein; Michael W Kattan; Fernando P Secin; Bertrand D Guilloneau; Peter T Scardino
Journal:  Int J Cancer       Date:  2010-06-09       Impact factor: 7.396

2.  Genome-wide association study of prostate cancer mortality.

Authors:  Kathryn L Penney; Saumyadipta Pyne; Fredrick R Schumacher; Jennifer A Sinnott; Lorelei A Mucci; Peter L Kraft; Jing Ma; William K Oh; Tobias Kurth; Philip W Kantoff; Edward L Giovannucci; Meir J Stampfer; David J Hunter; Matthew L Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

3.  The value of the 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system as a predictor of biochemical recurrence after radical prostatectomy.

Authors:  Athanase Billis; Maisa M Q Quintal; Luciana Meirelles; Leandro L L Freitas; Larissa B E Costa; João F L Bonfitto; Betina L Diniz; Paola H Poletto; Luís A Magna; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2013-10-06       Impact factor: 2.370

4.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

5.  Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.

Authors:  Kathryn L Penney; Claudia A Salinas; Mark Pomerantz; Fredrick R Schumacher; Christine A Beckwith; Gwo-Shu Lee; William K Oh; Oliver Sartor; Elaine A Ostrander; Tobias Kurth; Jing Ma; Lorelei Mucci; Janet L Stanford; Philip W Kantoff; David J Hunter; Meir J Stampfer; Matthew L Freedman
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.